Device developer Merxin has announced the availability of its MRX001 “off the shelf” multidose dry powder inhaler.
According to an announcement on the website of Merxin sister company Aedestra, the blister-based DPI is designed for developers of generic combination products planning to submit a 505(j) application.
Read the Aedestra announcement.
published on
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
December 9-December 11: DDL 2026, Edinburgh, Scotland
April 27-30: RDD Europe 2027, Antibes, France
May 12-13: USP Joint Workshop: Quality and Product Performance Testing of Orally Inhaled and Nasal Drug Products, Rockville, MD, USA
June 30: RespireX 2027, Boston, MA, USA
